Mark Christopher Capone, Chief Operating Officer, MGL at MYRIAD GENETICS INC (MYGN), sold 18,000 shares at $67.93 ($1.2M) on 2008-08-29, disclosed to the SEC on 2008-09-03.
Open-market sale of $1.2M MYGN by Chief Operating Officer, MGL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.93 | 2,030 | $138K | 11.3% |
| 2 | $67.93 | 2,316 | $157K | 12.9% |
| 3 | $67.93 | 3,000 | $204K | 16.7% |
| 4 | $67.93 | 5,184 | $352K | 28.8% |
| 5 | $67.93 | 5,470 | $372K | 30.4% |
| Total | $67.93 avg | 18,000 |
| $1.2M |
| 100% |
| Filing → |
| MYGN | SELL | 2018-07-13 | $3.3M | — | Filing → |
| MYGN | SELL | 2018-06-01 | $3.4M | — | Filing → |
| MYGN | BUY | 2016-08-19 | $425K | — | Filing → |